Phase II, Open Label Study of Ispinesib in Subjects With Advanced or Metastatic Breast Cancer

Trial Profile

Phase II, Open Label Study of Ispinesib in Subjects With Advanced or Metastatic Breast Cancer

Completed
Phase of Trial: Phase II

Latest Information Update: 09 Oct 2008

At a glance

  • Drugs Ispinesib (Primary)
  • Indications Advanced breast cancer
  • Focus Therapeutic Use
  • Sponsors GlaxoSmithKline
  • Most Recent Events

    • 09 Oct 2008 Checked against ClinicalTrials.gov record - last updated 9 Oct 2008.
    • 05 Dec 2006 Status change
    • 19 Aug 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top